![Nathan D. Trinklein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nathan D. Trinklein
Fondateur chez
SwitchGear Genomics, Inc.
Profil
Nathan D.
Trinklein is the founder of SwitchGear Genomics, Inc., founded in 2006.
Dr. Trinklein holds the titles of Chief Executive Officer & Director at SwitchGear Genomics, Inc. Dr. Trinklein is also the founder of Rondo Therapeutics, Inc...
Dr. Trinklein earned a doctorate degree from Stanford University.
Postes actifs de Nathan D. Trinklein
| Sociétés | Poste | Début |
|---|---|---|
SwitchGear Genomics, Inc.
 SwitchGear Genomics, Inc. BiotechnologyHealth Technology Provides products for studying regulatory elements in the human genome | Fondateur | 01/01/2006 |
Rondo Therapeutics, Inc.
 Rondo Therapeutics, Inc. BiotechnologyHealth Technology Develops immune-cell engaging bispecific antibodies | Fondateur | - |
Formation de Nathan D. Trinklein
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
SwitchGear Genomics, Inc.
SwitchGear Genomics, Inc. BiotechnologyHealth Technology Provides products for studying regulatory elements in the human genome | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rondo Therapeutics, Inc.
Rondo Therapeutics, Inc. BiotechnologyHealth Technology Develops immune-cell engaging bispecific antibodies | Health Technology |
